Climate Change Data

Environmental Metrics

ESG Focus Areas

• Social Responsibility
• Community Investment
• Public Health

Environmental Achievements

• Not disclosed

Social Achievements

• Acquired naming rights for Fukuda Denshi Arena, contributing to community health and sports.
• Installation of AEDs in Fukuda Denshi Arena and Tokyo Metro stations to improve public safety.

Governance Achievements

• Not disclosed

Climate Goals & Targets

Environmental Challenges

• Difficult market environment due to healthcare system reforms and price revisions.
• Decreased profitability due to increased price competition and large-scale business deals.

Mitigation Strategies

• Focus on market share expansion, consumable/maintenance service business, and overseas business expansion.
• Launch of new products with unique features and enhanced product lineup.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Not disclosed

Environmental Metrics

ESG Focus Areas

• Social Responsibility (CSR)
• Governance
• Community Investment
• Environmental Initiatives (Green Procurement)

Environmental Achievements

• Implemented "waterless printing" using 100% vegetable oil ink.

Social Achievements

• Established the Fukuda Memorial Medical Technology Promotion Foundation in 1990, providing grants for medical technology research.
• Acquired the naming rights to Chiba City Soga Stadium, renaming it "Fukuda Denshi Arena", contributing to community sports and health.
• Planned to provide 100 free seats at the Fukuda Denshi Arena for Chiba citizens for each game.
• Installed 11 AEDs in the arena to support the health of visitors, athletes, and staff.

Governance Achievements

• Held 17 board meetings to oversee operations and make important decisions.
• Held monthly management meetings to discuss key executive policies.
• Established a president's office for group management, guidance, information management, and timely disclosure of corporate information.
• Conducted internal audits through a department directly under the president, reporting results to the board of auditors.
• All auditors were external.
• Implemented a takeover defense plan approved by 80% of shareholders.

Climate Goals & Targets

Environmental Challenges

• Decreased operating profit due to share expansion policy leading to lower profit margins and increased investment in human resources, R&D, and internal controls.
• Significant decrease in net income due to losses from the withdrawal of two overseas subsidiaries.
• Stricter regulations and increased corporate responsibility for safety and quality of medical devices following the 2005 amendment of the Pharmaceutical Affairs Law.
• Increased competition in the medical device industry due to government policies aimed at controlling medical expenses.
• Shifting healthcare landscape from inpatient to outpatient care and from treatment to prevention.
• Challenges in expanding overseas sales, particularly in North America.
• Increased reliance on other companies' products due to increased large-scale orders.
• Rising cost of goods sold due to increased large-scale orders.
• Increased selling, general, and administrative expenses due to investment in overseas expansion, R&D, and internal control systems.

Mitigation Strategies

• Shifting from share expansion to profit-oriented strategy.
• Focusing on developing competitive new products that meet user needs.
• Expanding maintenance and service business to improve profit margins and reduce cost ratios.
• Increasing the ratio of in-house products to 60% to improve profitability.
• Implementing business process reviews to reduce total costs.
• Strengthening R&D investment to maintain competitiveness.
• Strengthening internal control systems to ensure management soundness and transparency.
• Establishing a specialized sales company, Fukuda Cardiac Lab Co., Ltd., to handle advanced medical materials.
• Strengthening overseas sales networks by establishing bases in North America and Europe.

Supply Chain Management

Climate-Related Risks & Opportunities

Environmental Metrics

ESG Focus Areas

• Not disclosed

Environmental Achievements

• Not disclosed

Social Achievements

• Not disclosed

Governance Achievements

• Not disclosed

Climate Goals & Targets

Environmental Challenges

• Not disclosed

Mitigation Strategies

• Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Not disclosed

Environmental Metrics

ESG Focus Areas

• Not disclosed

Environmental Achievements

• Not disclosed

Social Achievements

• Not disclosed

Governance Achievements

• Not disclosed

Climate Goals & Targets

Environmental Challenges

• COVID-19 pandemic impact on supply chain and market demand.
• Consumption tax increase impact (2019) leading to a decrease in demand in the second half of the fiscal year.

Mitigation Strategies

• Prioritized maintaining medical equipment supply to support healthcare workers.
• Implemented measures to improve profitability in overseas business.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Not disclosed